Effects of Early Pharmacist Intervention on Antimicrobial Therapy for Severe Hospital-Acquired Pneumonia

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.12-00257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

The Challenge of Antimicrobial Prescribing for Hospital-Acquired Pneumonia

Journal of Hospital Infection
MedicineInfectious DiseasesMicrobiology
2020English

Antimicrobial Therapy for Community-Acquired Pneumonia in Adults

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2002English

Severe Community-Acquired Pneumonia: Risk Factors for In-Hospital Mortality

Critical Care
Critical CareIntensive Care Medicine
2012English

Severe Community Acquired Pneumonia Update: Mortality, Mechanisms and Medical Intervention

Critical Care
Critical CareIntensive Care Medicine
2008English

Duration of Antimicrobial Therapy in Community Acquired Pneumonia: Less Is More

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2014English

Hydrocortisone Infusion for Severe Community-Acquired Pneumonia

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2005English

Severe Sepsis in Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2006English

The Early Mobility Bundle: A Simple Enhancement of Therapy Which May Reduce Incidence of Hospital-Acquired Pneumonia and Length of Hospital Stay

Journal of Hospital Infection
MedicineInfectious DiseasesMicrobiology
2014English

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

Internal Medicine
Internal MedicineMedicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy